Wouter Verhoeven

Questioner
DISC Type : c

Chief Executive Officer at Brandaris Therapeutics

Netherlands

Overview

Wouter Verhoeven is a seasoned biotech executive with over 20 years of experience, specializing in business development, M&A, and private equity. He holds an MSc from Delft University of Technology and currently serves as CEO of Brandaris Therapeutics and Venture Partner at BGV, previously leading NBE-Therapeutics to its acquisition by Boehringer Ingelheim.

Beyond his corporate roles, Wouter is a creative individual with a passion for writing. He has explored his talents as an author, successfully publishing his own childrens book, an accomplishment he celebrated with a launch party. This reveals a personal interest in storytelling and engaging with a younger audience through literature.

Unique fact: This biotech CEO and venture capitalist is also a published childrens book author, having written "De Nachtkluis".

Personality Overview

Cautious & Analytical

Not Easily Convinced

Price-Sensitive

While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters.  They generally do not appreciate an overfriendly approach and prefer to stay to-the-point. They prefer to analyze every situation thoroughly.


Topics They Care About

Biotech Venture Capital
As Venture Partner at BGV and with a background in private equity, he is deeply involved in identifying and funding early-stage European biotech companies.
M&A Deals
He has extensive experience in M&A, in- and out-licensing, and was instrumental in the acquisition of NBE-Therapeutics by Boehringer Ingelheim.
Autoimmune Disease Therapies
As CEO of dualyx, he led the company in raising €40 million to advance its portfolio of Treg therapies for autoimmune diseases into clinical trials.

Media Appearances

Wouter has no verified media appearances

Work History

11-2024
Chief Executive Officer at Brandaris Therapeutics
9-2021
Venture Partner at BGV (BioGeneration Ventures)
9-2021 - 11-2025
Chief Executive Officer at dualyx
1-2019 - 7-2021
Chief Business Officer at NBE-Therapeutics
Head of Global Business and Corporate Development, member of the Executive Committee at mAbxience

Education

1997 - 2003
MSc from Delft University of Technology
1989 - 1996
Education details unavailable from Hertog Jan College

More Information

Social Presence :

Prographics :

Exp : 6 Location : Netherlands Job Level : Leadership Designation : Chief Executive Officer at Brandaris Therapeutics
URL has been copied!

Insights For Selling To Wouter

During A Call Or A Meeting

DO's

  • Keep some extra margin in hand as they will likely negotiate the pricing
  • If you have a lower priced product compared to the competition, call out the same
  • Tell them that you will come back if you don’t have a good answer for a question

DONT's

  • Don’t overhype the product/pitch, keep it measured
  • Avoid phrases like ‘do not worry about’, ‘no one compares to’ etc.
  • Don’t try to be too friendly or informal with them

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Wouter is

  • Confidence that the product provides ROI, effective pricing and process adherence matter the most to them.

  • Will you ever get a clear answer from Wouter

  • It doesn’t come naturally to them but they can say no if they are not convinced.

Insights For Deal Planning

    How fast (or slow) will Wouter move?

  • They can move at a reasonable pace while making their decisions if they have the necessary information.

  • Can Wouter take some risk or not?

  • They can take risk if they are convinced that they have analyzed the circumstances well.


You And Wouter

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.